The cellular chaperone, HSP90, is identified here as an essential factor for the activity of NS2͞3 protease of hepatitis C virus. The cleavage activity of NS2͞3 protease synthesized in reticulocyte lysate is ATP-dependent, as evidenced by ATP depletion experiments and inhibition with nonhydrolyzable ATP analogs. Geldanamycin and radicicol, ATP-competitive inhibitors of the chaperone HSP90, also inhibit the cleavage of in vitro-synthesized NS2͞3. Furthermore, these HSP90 inhibitors prevent NS2͞3 cleavage when the protease is expressed in mammalian cells. The physical association of NS2͞3 with HSP90 is demonstrated by immunoprecipitation. Thus, by way of a chaperone͞folding activity, an HSP90-containing complex is required for maturation of the polyprotein that encodes the enzymes essential for hepatitis C virus replication.A n estimated 170 million people are infected with hepatitis C virus (HCV) worldwide. The infection is usually persistent, and after an asymptomatic period often lasting years, many patients develop chronic liver disease, including cirrhosis and hepatocellular carcinoma (1, 2). The preferred existing treatment with IFN-␣ is successful in only a small fraction of cases, so an urgent need exists for the development of therapeutically effective inhibitors of HCV replication. With the precedent of numerous successful antiviral therapies based on viral enzyme inhibition, the enzymes encoded by HCV present particularly attractive targets. The recombinant HCV enzymes, NS5B RNA polymerase, NS3 protease, and NS3 helicase have been purified, their enzymatic properties are being defined in vitro, and their potential for inhibition is being explored by many laboratories (3-7).In contrast, the HCV protease activity responsible for cleavage between NS2 and the NS3 proteins, known as NS2͞3 protease, has been reported only in cell lysate translation systems and transfection experiments, despite having been described initially several years ago (8-10). Thus, NS2͞3 cleavage as a target for inhibition has been particularly refractory to detailed analysis, so that the definition of the critical components of this activity is needed. Based on mutational analyses, the protein region essential for NS2͞3 cleavage activity has been approximately mapped to amino acids 898-1207 of the HCV ORF. This region of the HCV polyprotein includes the N-terminal portion of NS3 that is known to be sufficient for NS3 protease activity, residues 1027-1207. Because of the overlap of sequence essential for the two distinct protease activities, it is worthwhile to emphasize that the NS3 protease activity can be totally eliminated through mutagenesis of the NS3 active site Ser-1165 without affecting NS2͞3 cleavage activity (10).Additional features of NS2͞3 cleavage activity known at this time include identification of Cys-993 and His-952 as essential residues (8-13). The only known cleavage site sequence, ArgLeu-Leu2Ala-Pro-Ile, is conserved across HCV strains, and the catalytic mechanism of NS2͞3 cleavage is unknown, but the enzyme is sp...